FDA Denies Pfizer Petition Asking for New Method of Assessing Premarin Generics

Drug Industry Daily
A A
The FDA has denied a citizen petition from Pfizer calling on the agency to use the company’s method for assessing sameness in generics for its estrogen drug Premarin (conjugated estrogens).

To View This Article:

Login

Subscribe To Drug Industry Daily